- Home
- ACEL vs IMNM Comparison
ACEL vs IMNM Comparison
Compare ACEL & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACEL
- IMNM
- Stock Information
- Founded
- ACEL 2009
- IMNM 2006
- Country
- ACEL United States
- IMNM United States
- Employees
- ACEL 1500
- IMNM N/A
- Industry
- ACEL Services-Misc. Amusement & Recreation
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- ACEL Consumer Discretionary
- IMNM Health Care
- Exchange
- ACEL Nasdaq
- IMNM Nasdaq
- Market Cap
- ACEL 1.1B
- IMNM 945.8M
- IPO Year
- ACEL N/A
- IMNM 2020
- Fundamental
- Price
- ACEL $12.80
- IMNM $10.71
- Analyst Decision
- ACEL Buy
- IMNM Strong Buy
- Analyst Count
- ACEL 1
- IMNM 5
- Target Price
- ACEL $16.00
- IMNM $26.40
- AVG Volume (30 Days)
- ACEL 253.2K
- IMNM 965.4K
- Earning Date
- ACEL 08-05-2025
- IMNM 08-11-2025
- Dividend Yield
- ACEL N/A
- IMNM N/A
- EPS Growth
- ACEL N/A
- IMNM N/A
- EPS
- ACEL 0.49
- IMNM N/A
- Revenue
- ACEL $1,253,067,000.00
- IMNM $10,938,000.00
- Revenue This Year
- ACEL $9.34
- IMNM N/A
- Revenue Next Year
- ACEL $4.61
- IMNM $259.34
- P/E Ratio
- ACEL $26.27
- IMNM N/A
- Revenue Growth
- ACEL 6.28
- IMNM N/A
- 52 Week Low
- ACEL $9.02
- IMNM $5.15
- 52 Week High
- ACEL $13.26
- IMNM $16.81
- Technical
- Relative Strength Index (RSI)
- ACEL 68.21
- IMNM 60.20
- Support Level
- ACEL $12.03
- IMNM $10.33
- Resistance Level
- ACEL $13.28
- IMNM $11.08
- Average True Range (ATR)
- ACEL 0.31
- IMNM 0.60
- MACD
- ACEL 0.04
- IMNM 0.04
- Stochastic Oscillator
- ACEL 77.20
- IMNM 72.31
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.